Corner Office Conversation
Corner Office Conversation
Podcast Description
Corner Office Conversation is The Economic Times’ flagship interview podcast featuring unfiltered, one-on-one conversations with some of India and the world’s most powerful business leaders.
Hosted by ET’s top journalists and editors, this fortnightly show goes beyond headlines and press releases to explore how CEOs and founders think, decide, and lead in an era of disruption.
From Marc Benioff (Salesforce), Dara Khosrowshahi (Uber), and Roland Busch (Siemens) to Adar Poonawalla (Serum Institute), Suresh Narayanan (Nestlé India), and Ravi Kumar S (Cognizant), these conversations uncover personal leadership playbooks, global strategy pivots, lessons from failures, and bold visions for the future — across industries like tech, healthcare, manufacturing, finance, and consumer goods.
New episodes drop every alternate Monday.
Podcast Insights
Content Themes
The podcast tackles a range of themes including leadership, innovation, and industry transformations with specific episodes exploring how leaders manage change in sectors like pharma and space. For instance, one episode discusses India’s transition in the pharma sector with insights from executives like Namita Thapar, focusing on regulatory challenges and the push towards patient-first approaches, while another episode featuring Pawan Goenka addresses the burgeoning Indian space economy.
Corner Office Conversation is The Economic Times’ flagship interview podcast featuring unfiltered, one-on-one conversations with some of India and the world’s most powerful business leaders.
Hosted by ET’s top journalists and editors, this fortnightly show goes beyond headlines and press releases to explore how CEOs and founders think, decide, and lead in an era of disruption.
From Marc Benioff (Salesforce), Dara Khosrowshahi (Uber), and Roland Busch (Siemens) to Adar Poonawalla (Serum Institute), Suresh Narayanan (Nestlé India), and Ravi Kumar S (Cognizant), these conversations uncover personal leadership playbooks, global strategy pivots, lessons from failures, and bold visions for the future — across industries like tech, healthcare, manufacturing, finance, and consumer goods.
New episodes drop every alternate Monday.
Qure.ai is transforming routine medical imaging into early disease detection at unprecedented scale. Processing nearly 1,000 patients per hour across 105 countries, the startup has made preliminary radiology reports at India’s AIIMS and CMC Vellore AI-powered often flagging diseases physicians weren’t even looking for. In this conversation, Vikas Dandekar speaks with Prashant Warier Co-founder & CEO, Ankit Modi, Founding Member and Chief Product Officer and Preetham Putha, Founding Member and Chief AI Officer about how Qure.ai is reimagining diagnostics. Their breakthrough includes risk-scoring algorithms that detect high-risk lung nodules on standard chest X-rays, achieving a 54% CT-confirmed malignancy rate. From TB screening programs in Mumbai. where their tools uncovered 35% more cases for lung cancer detection in US hospitals, Qure.ai now holds 19 FDA clearances and WHO endorsement for autonomous AI diagnosis. Founded in 2016 and trained on over 1.5 billion anonymized images, Qure.ai has published clinical evidence in The Lancet and Nature. With current revenues of ₹200 crore, the company is targeting profitability within two years while scaling toward its ambition of impacting 1 billion lives by 2030.
See omnystudio.com/listener for privacy information.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.